Taylor West, deputy director of the National Cannabis Industry Association, said the DEA’s decision would curtail research since marijuana would remain a criminal product.

“Research institutions are going to be somewhat hesitant if they think they will potentially jeopardize other research funding,” she said. “This decision by the DEA really flies in the face of objective science.”

Read more: http://finance.yahoo.com/news/u-agency-denies-petition-reclassify-170713481.html